SecBot SecBot
SECBOTREPLAY Home › Report › MDLN

MDLN · IPO effective, 60M share sale

Medline Inc. · EFFECT filed Nov 18, 2026 at 00:15 ET

At the news

NEUTRALIMPACT 5/10

EFFECT filed Nov 18, 2026 at 00:15 ET

The SEC declared Medline Inc.'s S-1 registration statement (File No. 333-300065) effective on November 17, 2026. This clears the way for a secondary offering of 60 million shares by selling stockholders and a concurrent $200 million share repurchase by the company, as detailed in the prior S-1 filing. The company receives no proceeds from the offering.

  • Effectiveness date: November 17, 2026
  • Registration statement File No. 333-300065 declared effective
  • Underlying S-1 (filed Nov 16, 2026) covers secondary offering of 60M shares by selling stockholders
  • Concurrent $200M repurchase of shares and units is conditioned on the offering closing

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access